Published in Med Oncol on September 08, 2007
A double-blinded, randomized controlled trial of zoledronate therapy for HIV-associated osteopenia and osteoporosis. AIDS (2009) 0.94
Clinical role of bisphosphonate therapy. Int J Womens Health (2012) 0.85
Zoledronic acid: clinical utility and patient considerations in osteoporosis and low bone mass. Drug Des Devel Ther (2010) 0.81
Acute uveitis following zoledronic acid infusion. Oman J Ophthalmol (2009) 0.77
Orbital inflammatory disease secondary to a single-dose administration of zoledronic acid for treatment of postmenopausal osteoporosis. Osteoporos Int (2009) 0.76
Severe polyarthritis secondary to zolendronic acid: a case report and literature review. Clin Cases Miner Bone Metab (2015) 0.75
Acute bilateral uveitis and right macular edema induced by a single infusion of zoledronic acid for the treatment of postmenopausal osteoporosis as a substitution for oral alendronate: a case report. BMC Musculoskelet Disord (2016) 0.75
Rituximab-related viral infections in lymphoma patients. Leuk Lymphoma (2007) 2.55
Infectious complications of rituximab in patients with lymphoma during maintenance therapy: a systematic review and meta-analysis. Leuk Lymphoma (2009) 1.09
Choroidal mass as an initial presentation of lung cancer. Med Oncol (2008) 1.02
Tissue glue in sutureless vitreoretinal surgery for the treatment of wound leakage. Ophthalmic Surg Lasers Imaging (2008) 1.00
Systemic treatment in breast-cancer patients with brain metastasis. Expert Opin Pharmacother (2010) 0.95
Breast cancer subtypes and outcomes of central nervous system metastases. Breast (2011) 0.92
Zoledronic acid and atrial fibrillation in cancer patients. Support Care Cancer (2010) 0.92
Characteristics of breast cancer patients with central nervous system metastases: a single-center experience. J Natl Med Assoc (2008) 0.90
Orbital metastasis from adenocarcinoma of the colon. South Med J (2005) 0.88
Demographic and clinico-pathological characteristics in patients with triple-negative and non-triple-negative breast cancer. Med Oncol (2010) 0.88
The relation between bevacizumab injection and the formation of subretinal fibrosis in diabetic patients with panretinal photocoagulation. Ophthalmic Surg Lasers Imaging (2010) 0.86
Outcomes of locally advanced breast cancer patients with ≥ 10 positive axillary lymph nodes. Med Oncol (2013) 0.86
Best's vitelliform macular dystrophy with pseudohypopyon: an optical coherence tomography study. Am J Ophthalmol (2004) 0.85
Blood ABO groups and risk of breast cancer. Med Oncol (2010) 0.84
Low ERCC1 expression is associated with prolonged survival in patients with bladder cancer receiving platinum-based neoadjuvant chemotherapy. Urol Oncol (2012) 0.83
Pharmacotherapy of triple-negative breast cancer. Expert Opin Pharmacother (2009) 0.83
Concomitant Mycobacterium tuberculosis and Aspergillus niger infection in a patient with acute myeloid leukemia. Chemotherapy (2003) 0.82
Vogt-Koyanagi-Harada syndrome in children: report of a case and review of the literature. Ocul Immunol Inflamm (2007) 0.82
Thoracic paravertebral leiomyosarcoma: rare but it does occur. Spine (Phila Pa 1976) (2002) 0.81
Good outcomes of patients with stage IB endometrial cancer with surgery alone. Asian Pac J Cancer Prev (2014) 0.81
"Unfit" for Cisplatin: on basis of which GFR? J Clin Oncol (2011) 0.81
Dasatinib may also inhibit c-Kit in triple negative breast cancer cell lines. Breast Cancer Res Treat (2007) 0.80
Siderosis bulbi resulting from an unknown intraocular foreign body. J Trauma (2008) 0.80
Changes of total antioxidant capacity and total oxidant status of aqueous humor in diabetes patients and correlations with diabetic retinopathy. Int J Ophthalmol (2013) 0.80
Two important determinants may play a role in the success of the FinHer Trial. J Clin Oncol (2010) 0.79
Post-diagnosis statin use and breast recurrence sites in early stage breast cancer survivors. Breast Cancer Res Treat (2007) 0.79
Association of breast cancer subtypes and body mass index. Tumori (2013) 0.79
Erythropoiesis-stimulating agents in the treatment of cancer-associated anemia. JAMA (2008) 0.79
Sparing of previously irradiated skin from erlotinib-induced acneiform rash. J Am Acad Dermatol (2008) 0.79
Prophylactic human papilloma virus vaccines for cervical cancer may also prevent development of breast and oropharyngeal cancers in women. Med Hypotheses (2006) 0.79
Chemotherapy and biological treatment options in breast cancer patients with brain metastasis: an update. Expert Opin Pharmacother (2014) 0.79
Effects of growth factors on doxorubicin-induced skin necrosis: documentation of histomorphological alterations and early treatment by GM-CSF and G-CSF. Ann Plast Surg (2002) 0.79
Mammalian telomeric DNA suppresses endotoxin-induced uveitis. J Biol Chem (2010) 0.78
Phase II study of loading-dose ibandronate treatment in patients with breast cancer and bone metastases suffering from moderate to severe pain. Onkologie (2012) 0.78
Usher syndrome associated with a variant of Dandy-Walker malformation. J Pediatr Ophthalmol Strabismus (2010) 0.78
Prolonged anti-HAV IgM positivity in a pregnant woman. Indian J Gastroenterol (2005) 0.78
Increased mean corpuscular volume of erythrocytes during capecitabine treatment: a simple surrogate marker for clinical response. Tumori (2012) 0.78
Weekly paclitaxel in the adjuvant treatment of breast cancer. N Engl J Med (2008) 0.77
Vitamin D intake and breast cancer risk in postmenopausal women. Arch Intern Med (2007) 0.77
Erectile dysfunction in successfully treated lymphoma patients. Support Care Cancer (2007) 0.77
Short-term effects of subconjunctival injections of 5-fluorouracil on conjunctival epithelium. Cornea (2010) 0.77
Reproductive and hormonal risk factors for postmenopausal luminal, HER-2-overexpressing, and triple-negative breast cancer. Cancer (2009) 0.77
Seropositive arthritis in chronic lymphocytic leukemia: a remark on B cell-mediated autoimmunity. Rheumatol Int (2005) 0.76
Albumin-bound paclitaxel, ABI-007 may show better efficacy than paclitaxel in basal-like breast cancers: association between caveolin-1 expression and ABI-007. Breast Cancer Res Treat (2006) 0.76
Alterations of von Willebrand factor and ristocetin cofactor activity during atrial fibrillation. Clin Appl Thromb Hemost (2007) 0.76
Clinical and pathological characteristics of breast cancer patients with history of cesarean delivery. Breast (2009) 0.76
Vitamin D supplementation and response to aromatase inhibitors in postmenopausal women with hormone-receptor positive breast cancer. Breast (2007) 0.76
Emerging drugs in metastatic breast cancer: an update. Expert Opin Emerg Drugs (2011) 0.75
Regional lymph node status in patients with bladder cancer found to be pathological stage T0 at radical cystectomy following systemic chemotherapy. BJU Int (2011) 0.75
Efficacy of anastrozole on local recurrence in patients with favorable early breast cancer. Int J Radiat Oncol Biol Phys (2007) 0.75
Role of trastuzumab in patients with brain metastases from Her2 positive breast cancer. J Neurooncol (2007) 0.75
Bisphosphonate use and prevalence of breast arterial calcification on mammography. Maturitas (2007) 0.75
Vogt-Koyanagi-Harada disease: clinical and demographic characteristics of patients in a specialized eye hospital in Turkey. Ocul Immunol Inflamm (2013) 0.75
Bone mineral density in breast cancer patients with estrogen receptor-negative tumor. Maturitas (2007) 0.75
Breast arterial calcification is associated with an increased prevalence of both cardiovascular risk factors and cardiovascular morbidity. Menopause (2008) 0.75
Estrogen receptor immunohistochemistry cutoff value: standardization is needed. Hum Pathol (2009) 0.75
Prognostic factors in breast cancer patients with brain metastases. J Neurooncol (2007) 0.75
p53 status in locally advanced bladder cancer. J Clin Oncol (2011) 0.75
Efficacy of chemotherapy for brain metastases from breast carcinoma: in regard to Le Scodan et al. (Int J Radiat Oncol Biol Phys 2007;69:839-845). Int J Radiat Oncol Biol Phys (2008) 0.75
Renal safety and osteonecrosis of the jaw in cancer patients receiving intravenous bisphosphonates. Med Oncol (2009) 0.75
Chemotherapy in older women with breast cancer. N Engl J Med (2009) 0.75
Potential targeted therapy options in the management of basal cell subtype of breast carcinoma. Hum Pathol (2007) 0.75
Re: E. Jason Abel, Stephen H. Culp, Nizar M. Tannir, et al. Primary tumor response to targeted agents in patients with metastatic renal cell carcinoma. Eur Urol 2011;59:10-5. Eur Urol (2011) 0.75
Prognostic factors in long-term breast cancer survivors with brain metastases. Breast Cancer Res Treat (2007) 0.75
Clinical and pathological characteristics of breast cancer patients with history of tonsillectomy. Breast (2010) 0.75
Oral contraceptive use and estrogen receptor-negative breast cancer. Am Surg (2011) 0.75
Tumor lysis syndrome associated with fludarabine treatment in chronic lymphocytic leukemia. Ann Pharmacother (2004) 0.75
Impact of panretinal photocoagulation on optic nerve head parameters. Ophthalmologica (2011) 0.75
Relapsed prolactinoma 27 years after conventional radiotherapy. Am J Clin Oncol (2002) 0.75
Adrenal cortical carcinoma presenting initially with radius metastasis. Clin Oncol (R Coll Radiol) (2002) 0.75
Oncocytic carcinoma of the breast: rare histology. Am Surg (2010) 0.75
Mucosa associated lymphoid tissue lymphoma of the sub-mandibular gland presenting with relapse in the lacrimal gland. Leuk Lymphoma (2006) 0.75
Nasopharynx carcinoma complicated with pneumocephalus. J Neurooncol (2005) 0.75
Familial chemosensitivity test: can it be a predictive factor in the management of familial breast cancer? Breast (2007) 0.75
Stroke due to doxorubicin-induced cardiac toxicity. Med Oncol (2008) 0.75
Fusobacterium and Colorectal Carcinogenesis. Carcinogenesis (2017) 0.75
Adjuvant use of epidermal growth factor receptor kinase inhibitors may prevent bone metastases in patients with non-small cell lung carcinoma. J Thorac Oncol (2007) 0.75
Ipsilateral breast cancer in a patient with Poland's syndrome. Am Surg (2011) 0.75
Burnout syndrome during residency in internal medicine and pediatrics in a country without working time directive. Int J Health Care Qual Assur (2014) 0.75
A facade of initial sacroiliac manifestation in Hodgkin disease. Ann Hematol (2007) 0.75
Vitamin D intake may be a predictor of response to aromatase inhibitors in postmenopausal women with hormone receptor positive breast cancer. Breast Cancer Res Treat (2007) 0.75
Idiopathic episcleral venous engorgement. Clin Exp Optom (2009) 0.75
Other malignancies in patients with breast cancer: a single institute experience. Med Oncol (2010) 0.75
Is thermal laser the first but the best choice of treatment for the extrafoveal choroidal neovascularisation? Clin Exp Optom (2010) 0.75
Definition of postmenopausal status, age of the breast cancer patients and the outcome of aromatase inhibitors treatment. Breast (2008) 0.75
Coincidence of increased pulmonary artery pressure and patent septum foramen ovale in patients with solid tumors may have a propensity to develop central nervous system metastases. Med Hypotheses (2006) 0.75
A rare ocular complication after a heart transplant: toxoplasma retinitis. Exp Clin Transplant (2014) 0.75
Impact of treatment strategies on local control and survival in uterine carcinosarcomas in Turkey. Asian Pac J Cancer Prev (2013) 0.75